Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,768,240
-
Share change
-
-633,563
-
Total reported value
-
$105,683,058
-
Price per share
-
$8.98
-
Number of holders
-
62
-
Value change
-
-$4,606,165
-
Number of buys
-
29
-
Number of sells
-
19
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q3 2017
As of 30 Sep 2017,
RECRO PHARMA INC - COM (SCTL) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,768,240 shares.
The largest 10 holders included
Broadfin Capital, LLC, DEERFIELD MANAGEMENT CO, Stonepine Capital Management, LLC, BlackRock Inc., Alyeska Investment Group, L.P., VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., Tappan Street Partners LLC, Marshall Wace North America L.P., and CADENCE CAPITAL MANAGEMENT LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.